# ALX Oncology Holdings Inc: Form 8-K, filed Jan 17, 2025

- Company: [ALX Oncology Holdings Inc](/companies/alxo.md) (CIK 1810182)
- Form: 8-K
- Filed: 2025-01-17
- Accepted by EDGAR: Jan 17, 2025, 21:41 ET
- Period: 2025-01-16
- Accession: 0001193125-25-008461
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810182/000119312525008461/d909443d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810182/000119312525008461/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810182/000119312525008461/d909443d8k.htm

Filed Jan 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-008461. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.